| Trial ID: | L3766 |
| Source ID: | NCT02462369
|
| Associated Drug: |
Saxagliptin
|
| Title: |
Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Microalbuminuria|Microalbuminuria /Creatinine Ratios ACR
|
| Interventions: |
DRUG: Saxagliptin|DRUG: glimepiride
|
| Outcome Measures: |
Primary: microalbuminuria improvement in T2DM treated with saxagliptin, 52 weeks | Secondary: incidence of hypoglycaemia of saxagliptin or glimepiride, 52 weeks
|
| Sponsor/Collaborators: |
Sponsor: The Second Hospital of Nanjing Medical University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
88
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2015-06
|
| Completion Date: |
2017-10
|
| Results First Posted: |
|
| Last Update Posted: |
2015-07-28
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02462369
|
